Volume 16, Issue 7, July 2019 - First Report Managed Care
07/23/2019
Pharmaceutical developments are not keeping pace with mutations in antibiotics; and, while international stakeholders recognize the severity of antimicrobial resistance, new breakthroughs in technology are needed to combat this threat.
Pharmaceutical developments are not keeping pace with mutations in antibiotics; and, while international stakeholders recognize the severity of antimicrobial resistance, new breakthroughs in technology are needed to combat this threat.
Pharmaceutical developments are...
07/23/2019
First Report Managed Care
Department
Formulary Frontlines®
07/23/2019
Eileen Koutnik-Fotopoulos
Eileen Koutnik-Fotopoulos
While great strides have been made in treating people with HIV over the past few decades, the US Preventive Task Force is strongly recommending PrEP for anyone at risk to help prevent the spread of the disease with which approximately 1.1...
While great strides have been made in treating people with HIV over the past few decades, the US Preventive Task Force is strongly recommending PrEP for anyone at risk to help prevent the spread of the disease with which approximately 1.1...
While great strides have been...
07/23/2019
First Report Managed Care
Conference Insider
07/23/2019
An analysis presented at the American Diabetes Association’s 79th Scientific Sessions shows that patients with type 2 diabetes and moderate-to-severe chronic kidney disease who took 1.5 mg of dulaglutide once a week saw reduced clinical...
An analysis presented at the American Diabetes Association’s 79th Scientific Sessions shows that patients with type 2 diabetes and moderate-to-severe chronic kidney disease who took 1.5 mg of dulaglutide once a week saw reduced clinical...
An analysis presented at the...
07/23/2019
First Report Managed Care
Conference Insider
07/23/2019
Researchers at the American Diabetes Association’s 79th Scientific Sessions presented data showing an accelerated rate of serious complications within the last 5 years for young adults with youth-onset type 2 diabetes and call for more...
Researchers at the American Diabetes Association’s 79th Scientific Sessions presented data showing an accelerated rate of serious complications within the last 5 years for young adults with youth-onset type 2 diabetes and call for more...
Researchers at the American...
07/23/2019
First Report Managed Care
Conference Insider
07/23/2019
Technology is constantly evolving and the health care space is among the top industries benefiting from innovation. In a presentation at American Diabetes Association’s (ADA) 79th Scientific Sessions, a professional interest group presented...
Technology is constantly evolving and the health care space is among the top industries benefiting from innovation. In a presentation at American Diabetes Association’s (ADA) 79th Scientific Sessions, a professional interest group presented...
Technology is constantly...
07/23/2019
First Report Managed Care
Conference Insider
07/23/2019
According to a recent study, pancreatic beta cells that are not producing sufficient insulin in patients with type 2 diabetes are not actually permanently destroyed and through the removal of excess fat in the cells, could be restored.
According to a recent study, pancreatic beta cells that are not producing sufficient insulin in patients with type 2 diabetes are not actually permanently destroyed and through the removal of excess fat in the cells, could be restored.
According to a recent study,...
07/23/2019
First Report Managed Care
Conference Insider
07/23/2019
Researchers presented at ASCO’s 2019 Annual Meeting on the clinical benefits of gilteritinib FLT3-Mutated relapsed or refractory acute myeloid leukemia (R/R AML) compared with salvage chemotherapy.
Researchers presented at ASCO’s 2019 Annual Meeting on the clinical benefits of gilteritinib FLT3-Mutated relapsed or refractory acute myeloid leukemia (R/R AML) compared with salvage chemotherapy.
Researchers presented at ASCO’s...
07/23/2019
First Report Managed Care
Conference Insider
07/23/2019
Researchers from Levine Cancer Institute said that clinical pathways streamline evidence-based treatment decisions and provide consistent, high-quality, value-based care.
Researchers from Levine Cancer Institute said that clinical pathways streamline evidence-based treatment decisions and provide consistent, high-quality, value-based care.
Researchers from Levine Cancer...
07/23/2019
First Report Managed Care
Conference Insider
07/23/2019
A palliative care program launched at Michigan Health Professionals—a large community oncology practice participating in the Oncology Care Model (OCM)—provided more care at home and at a lower cost for participating patients.
A palliative care program launched at Michigan Health Professionals—a large community oncology practice participating in the Oncology Care Model (OCM)—provided more care at home and at a lower cost for participating patients.
A palliative care program...
07/23/2019
First Report Managed Care
Conference Insider
07/23/2019
America’s Health Insurance Plans (AHIP), the nation’s largest health insurance trade association, has recently announced a new initiative that addresses social barriers to good health.
America’s Health Insurance Plans (AHIP), the nation’s largest health insurance trade association, has recently announced a new initiative that addresses social barriers to good health.
America’s Health Insurance Plans...
07/23/2019
First Report Managed Care
Conference Insider
07/23/2019
According to data presented at the 2019 AHIP Institute & Expo, many patients with diabetes do not meet their glucose goals and often face high annual health care costs.
According to data presented at the 2019 AHIP Institute & Expo, many patients with diabetes do not meet their glucose goals and often face high annual health care costs.
According to data presented at...
07/23/2019
First Report Managed Care
